🇺🇸 IBI311 in United States

IBI311 (IBI311) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

IBI311 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is IBI311 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for IBI311 in United States?

Shanghai Changzheng Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.